Exephin 500 mg/vial is a third-generation cephalosporin antibiotic widely used for the treatment of serious bacterial infections. With its broad-spectrum activity against Gram-positive and Gram-negative bacteria, it provides potent bactericidal effects. Exephin 500 mg/vial is administered parenterally via intravenous (IV) or intramuscular (IM) injection, offering flexibility in treating hospitalized patients or those with severe infections. Its relatively long half-life allows for once-daily dosing in many clinical situations.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Third-generation cephalosporin antibiotic
Exephin 500 mg/vial is indicated for treating the following infections:
Lower respiratory tract infections: pneumonia, bronchitis
Acute bacterial otitis media
Skin and soft tissue infections
Urinary tract infections
Gonorrhea (uncomplicated cases)
Bacterial septicemia
Bone and joint infections
Meningitis
Prevention of postoperative infections
Perioperative prophylaxis associated with surgery
Its broad-spectrum activity and high tissue penetration make it effective in both community-acquired and hospital-acquired infections.
Exephin acts by inhibiting bacterial cell wall synthesis, binding to penicillin-binding proteins and preventing peptidoglycan cross-linking. This disrupts cell wall formation, leading to bacterial lysis. It is highly stable against beta-lactamases, which protects it from enzymatic degradation by resistant bacteria.
Protein binding: 95%
Plasma half-life: 6–9 hours
Excretion: 40–65% unchanged in urine; remainder via bile into feces
Metabolism: Not metabolized
Its pharmacokinetic profile supports once or twice-daily dosing, even in severe infections.
Adults:
Standard dose: 1–2 g IV or IM once daily (or in divided doses twice daily)
Maximum: 4 g/day
Gonorrhea: 250 mg IM single dose
Surgical prophylaxis: 1 g IV 30–120 minutes before surgery
Infants & Children (≥1 month):
General infections: 50–75 mg/kg IV/IM once daily (max 2 g/day)
Otitis media: 50 mg/kg IM single dose (max 1 g)
Meningitis: 100 mg/kg IV/IM once daily (max 4 g/day)
Administration:
IM injection: Dissolve in Lidocaine HCl 1%
IV injection: Dissolve in Water for Injection, administer over 2–4 minutes or by infusion over 30 minutes (10–40 mg/mL concentration)
Test dose recommended to check patient tolerance
Hypersensitivity to cephalosporins or other beta-lactam antibiotics
Exephin is generally well tolerated. Reported adverse reactions include:
Gastrointestinal: diarrhea, nausea, vomiting, stomatitis, glossitis
Cutaneous: rash, pruritus, urticaria, edema, erythema multiforme
Hematologic: eosinophilia, thrombocytopenia, leucopenia, anemia, neutropenia
Hepatic: elevated SGOT/SGPT, bilirubinemia
CNS: headache, dizziness, confusion, sleep disturbances, convulsions
Local: rare phlebitis at injection site, minimized with slow injection
Monitor for anaphylactic reactions; administer IV epinephrine and glucocorticoids if severe
Rare gallbladder “sludge” may occur, reversible on discontinuation
Prolonged therapy requires regular blood count monitoring
Not recommended for premature neonates or newborns ≤28 days
Use only if clearly indicated; safety in pregnancy not established
Low concentrations excreted in breast milk; caution advised
No specific antidote; treatment is supportive and symptomatic
Store in a cool, dry place below 30°C, away from light and moisture
Keep out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet